Cancer Meeting Focuses on Existing Drugs
One of the biggest challenges in modern-day cancer treatment is properly matching one or more of the many new cancer drugs to the patients most likely to respond. Consequently, much of the news coming out of the massive American Society of Clinical Oncology (ASCO) meeting focused on better ways to use existing treatments. More than 30,000 oncologists, scientists, and investors who attended the conference in Chicago May 30-June 3 came to learn.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Bitcoin Futures Deliver Wild Ride as Debut Brings Rally, Halts
- Investors Told to Brace for Steepest Rate Hikes Since 2006
- Longtime NPR Host Tom Ashbrook Is Facing Misconduct Allegations
- Times Square Subway Bomber Tells Police He’s a Follower of Islamic State
- Buffett's About to Get $3 Billion Back From Burger King Owner